Many of the details are still being worked out, as U.S. regulators review the first vaccine candidates, such as Pfizer’s.
U.S. mulls Pfizer vaccine approval: Here’s what we know about their rollout plan
© The Crystal Eyes
Many of the details are still being worked out, as U.S. regulators review the first vaccine candidates, such as Pfizer’s.
© The Crystal Eyes